ETNB · Categories · Form 4

ETNB - SEC Form 4 insider transactions

89bio Inc. (ETNB) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ETNB

• 219d
  Director Ra Capital Management, L.P. returned 19,889,683 shares to the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  Director Hayden Michael R closing all direct ownership in the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  Chief Financial Officer Martins Ryan was granted 35,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  SEC Form 4 filed by Director Altschuler Steven

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  Chief Executive Officer Palekar Rohan was granted 125,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  Director Mcwherter Charles closing all direct ownership in the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  SEC Form 4 filed by Director Atkinson Edward Morrow Iii

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  SEC Form 4 filed by Director Zoth Lota S.

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  Officer Le-Nguyen Quoc was granted 50,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  SEC Form 4 filed by Director Babler Martin

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  SEC Form 4 filed by Director Dirocco Derek

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  Chief Operating Officer Sarena Francis Willard closing all direct ownership in the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 223d
  Chief Medical Officer Mansbach Harry H was granted 50,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 230d
  Chief Financial Officer Martins Ryan exercised 80,799 shares at a strike of $3.17, increasing direct ownership by 31% to 339,295 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 309d
  Officer Le-Nguyen Quoc covered exercise/tax liability with 8,202 shares, decreasing direct ownership by 2% to 301,684 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 309d
  Chief Medical Officer Mansbach Harry H covered exercise/tax liability with 7,680 shares, decreasing direct ownership by 2% to 302,656 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 309d
  Chief Financial Officer Martins Ryan covered exercise/tax liability with 7,680 shares, decreasing direct ownership by 3% to 253,496 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 309d
  Chief Operating Officer Sarena Francis Willard covered exercise/tax liability with 6,185 shares, decreasing direct ownership by 8% to 74,231 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 309d
  Chief Executive Officer Palekar Rohan covered exercise/tax liability with 55,836 shares, decreasing direct ownership by 6% to 808,070 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 328d
  Officer Le-Nguyen Quoc sold $115,280 worth of shares (10,461 units at $11.02), decreasing direct ownership by 3% to 309,364 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 362d
  Chief Financial Officer Martins Ryan covered exercise/tax liability with 8,498 shares, decreasing direct ownership by 3% to 261,176 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 362d
  Chief Medical Officer Mansbach Harry H covered exercise/tax liability with 8,498 shares, decreasing direct ownership by 3% to 310,336 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 362d
  Officer Le-Nguyen Quoc covered exercise/tax liability with 9,032 shares, decreasing direct ownership by 3% to 319,825 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 419d
  Officer Le-Nguyen Quoc sold $91,208 worth of shares (15,329 units at $5.95), decreasing direct ownership by 4% to 328,323 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 476d
  Officer Le-Nguyen Quoc was granted 14,750 shares and covered exercise/tax liability with 1,050 shares, decreasing direct ownership by 0.30% to 343,652 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 476d
  Chief Financial Officer Martins Ryan covered exercise/tax liability with 780 shares, decreasing direct ownership by 0.29% to 269,674 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 476d
  Chief Medical Officer Mansbach Harry H covered exercise/tax liability with 1,050 shares, decreasing direct ownership by 0.33% to 318,834 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 476d
  Chief Executive Officer Palekar Rohan covered exercise/tax liability with 3,249 shares, decreasing direct ownership by 0.38% to 862,240 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 484d
  Chief Financial Officer Martins Ryan covered exercise/tax liability with 3,828 shares, decreasing direct ownership by 1% to 270,454 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 484d
  Officer Le-Nguyen Quoc covered exercise/tax liability with 3,793 shares, decreasing direct ownership by 1% to 344,702 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 484d
  Chief Executive Officer Palekar Rohan covered exercise/tax liability with 8,946 shares, decreasing direct ownership by 1% to 864,692 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 484d
  Chief Medical Officer Mansbach Harry H covered exercise/tax liability with 3,817 shares, decreasing direct ownership by 1% to 319,884 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Laporte Kathleen

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Zoth Lota S.

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Babler Martin

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Dirocco Derek

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Altschuler Steven

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Mcwherter Charles

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Atkinson Edward Morrow Iii

  4 - 89bio, Inc. (0001785173) (Issuer)
• 490d
  SEC Form 4 filed by Director Hayden Michael R

  4 - 89bio, Inc. (0001785173) (Issuer)
• 491d
  Chief Financial Officer Martins Ryan was granted 80,000 shares and covered exercise/tax liability with 3,338 shares, increasing direct ownership by 39% to 274,282 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 491d
  Officer Le-Nguyen Quoc was granted 80,000 shares and covered exercise/tax liability with 3,338 shares, increasing direct ownership by 28% to 348,495 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 491d
  Chief Executive Officer Palekar Rohan was granted 412,000 shares and covered exercise/tax liability with 9,598 shares, increasing direct ownership by 85% to 873,638 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 491d
  Chief Medical Officer Mansbach Harry H covered exercise/tax liability with 3,338 shares and was granted 80,000 shares, increasing direct ownership by 31% to 323,701 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 491d
  Chief Operating Officer Sarena Francis Willard was granted 53,750 shares, increasing direct ownership by 215% to 78,750 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 509d
  Officer Le-Nguyen Quoc sold $71,150 worth of shares (10,963 units at $6.49), decreasing direct ownership by 4% to 271,833 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 542d
  Chief Medical Officer Mansbach Harry H gave a grant of 95,000 shares, decreasing direct ownership by 28% to 247,039 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 542d
  Officer Le-Nguyen Quoc gave a grant of 95,000 shares, decreasing direct ownership by 25% to 282,796 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 542d
  Chief Financial Officer Martins Ryan gave a grant of 95,000 shares, decreasing direct ownership by 32% to 197,620 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 569d
  SEC Form 4 filed by Director Ra Capital Management, L.P.

  4 - 89bio, Inc. (0001785173) (Issuer)
• 586d
  Officer Le-Nguyen Quoc sold $226,995 worth of shares (27,955 units at $8.12), decreasing direct ownership by 13% to 187,796 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 638d
  Chief Financial Officer Martins Ryan covered exercise/tax liability with 3,212 shares, decreasing direct ownership by 3% to 102,620 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 638d
  Officer Le-Nguyen Quoc covered exercise/tax liability with 5,352 shares, decreasing direct ownership by 2% to 215,751 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 638d
  Chief Medical Officer Mansbach Harry H covered exercise/tax liability with 5,352 shares, decreasing direct ownership by 3% to 152,039 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 660d
  Chief Medical Officer Mansbach Harry H covered exercise/tax liability with 1,046 shares, decreasing direct ownership by 0.66% to 157,391 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 660d
  Chief Executive Officer Palekar Rohan covered exercise/tax liability with 4,601 shares, decreasing direct ownership by 1.00% to 456,236 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 660d
  Chief Financial Officer Martins Ryan covered exercise/tax liability with 777 shares, decreasing direct ownership by 0.73% to 105,832 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)
• 660d
  Officer Le-Nguyen Quoc covered exercise/tax liability with 1,046 shares, decreasing direct ownership by 0.47% to 221,103 units (SEC Form 4)

  4 - 89bio, Inc. (0001785173) (Issuer)

Other ETNB categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends